Thermo Fisher Scientific | TMO - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Abbott USD 5.86B 675M 2026-03
Agilent USD 946M 44M 2025-12
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Bio Techne USD 208.29M 17.01M 2026-03
Bio-Rad Laboratories USD 345.2M 1.8M 2025-12
Boston Scientific USD 3.61B 64M 2026-03
Bruker USD 379.8M 69.4M 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Danaher USD 3.59B 375M 2026-03
Dentsply International USD 427M 16M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
General Electric Aerospace USD 4.24B 439M 2026-03
Henry Schein USD 1.07B 7M 2026-03
Illumina USD 721M 38M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Laboratory Of America USD 1.01B 20.6M 2026-03
Medtronic USD 5.41B 27M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Olympus JPY 192.76B 27.86B 2026-03
OraSure Technologies USD 11.34M 435K 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Repligen USD 108.28M 4.45M 2026-03
Revvity USD 387.66M 34M 2026-03
Stryker USD 3.81B 675M 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Veracyte USD 101.16M 814K 2026-03
Waters USD 542M 15.42M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12